The world’s first clinical trial of brain stem cells to treat strokes is set to move to its next phase. An independent assessment of the first three patients to have had stem cells injected into their brain at Glasgow’s Southern General Hospital has concluded it has had no adverse effect. The assessment paves the way for the therapy to be tested on more patients to find a new treatment for stroke. The hope is that the stem cells will help to repair damaged brain tissue.
